Am­gen says FDA hold is lift­ed on its Phase 1 obe­si­ty can­di­date as Mar­i­Tide en­ters Phase 3

While Pfiz­er re­cent­ly pulled the plug on its most ad­vanced obe­si­ty can­di­date, Am­gen has moved its own key weight loss play in­to Phase 3 stud­ies …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.